Scott Terrillion Cara Therapeutics, Inc. (CARA) insider trading activity

CARA Quotes by TradingView

Scott Terrillion is SEC'Y; CHIEF COMPLIANCE & G.C. of Cara Therapeutics, Inc.. Currently has a direct ownership of 88,247 shares of CARA, which is worth approximately $40,593. The most recent transaction as insider was on Apr 05, 2024, when has been sold 2,753 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $2,284. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.2K
0% 3M change
0.36% 12M change
Total Value Held $40,593

Scott Terrillion Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2024
SELL
Open market or private sale
$2,284 $0.83 p/Share
2,753 Reduced 3.03%
88,247 Common Stock
Feb 29 2024
SELL
Open market or private sale
$2,930 $0.89 p/Share
3,293 Reduced 3.49%
91,000 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
13,500 Added 11.68%
102,063 Common Stock
Jun 23 2023
SELL
Open market or private sale
$8,715 $3.51 p/Share
2,483 Reduced 2.73%
88,563 Common Stock
Apr 04 2023
SELL
Open market or private sale
$12,181 $4.91 p/Share
2,481 Reduced 2.65%
91,046 Common Stock
Mar 03 2023
SELL
Open market or private sale
$60,745 $9.71 p/Share
6,256 Reduced 6.27%
93,527 Common Stock
Feb 08 2023
SELL
Open market or private sale
$4,118 $0.53 p/Share
7,770 Reduced 7.61%
94,293 Common Stock
Dec 21 2022
SELL
Open market or private sale
$28,862 $11.27 p/Share
2,561 Reduced 2.5%
99,783 Common Stock
Apr 01 2022
SELL
Open market or private sale
$19,556 $11.91 p/Share
1,642 Reduced 1.58%
102,344 Common Stock
Mar 03 2022
SELL
Open market or private sale
$20,336 $11.38 p/Share
1,787 Reduced 1.69%
103,986 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
5,333 Added 4.8%
105,773 Common Stock
Feb 25 2022
SELL
Open market or private sale
$20,292 $10.29 p/Share
1,972 Reduced 1.93%
100,440 Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 16.34%
102,412 Common Stock
Dec 17 2021
BUY
Grant, award, or other acquisition
-
11,495 Added 12.24%
82,412 Common Stock
Aug 30 2021
SELL
Open market or private sale
$24,978 $14.2 p/Share
1,759 Reduced 2.42%
70,917 Common Stock
Aug 24 2021
BUY
Grant, award, or other acquisition
-
5,334 Added 6.84%
72,676 Common Stock
Mar 30 2021
BUY
Grant, award, or other acquisition
-
16,000 Added 19.2%
67,342 Common Stock
Mar 05 2021
SELL
Open market or private sale
$55,558 $17.98 p/Share
3,090 Reduced 5.68%
51,342 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 15.52%
54,432 Common Stock
Feb 25 2021
SELL
Open market or private sale
$77,397 $19.33 p/Share
4,004 Reduced 8.27%
44,432 Common Stock
Feb 23 2021
BUY
Grant, award, or other acquisition
-
6,000 Added 11.02%
48,436 Common Stock
Dec 30 2020
SELL
Open market or private sale
$29,774 $15.3 p/Share
1,946 Reduced 4.38%
42,436 Common Stock
Dec 23 2020
BUY
Grant, award, or other acquisition
-
6,000 Added 11.91%
44,382 Common Stock
ST

Scott Terrillion

SEC'Y; CHIEF COMPLIANCE & G.C.
Stamford, CT

Track Institutional and Insider Activities on CARA

Follow Cara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

News

Receive news related to Cara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CARA